LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Antifungal Focus SCYNEXIS specializes in developing novel therapeutics for resistant fungal infections, presenting opportunities to collaborate or supply complementary products in the antimicrobial and infectious disease treatment markets.

Strategic Partnerships The company's partnerships with Hackensack Meridian CDI and Johns Hopkins signal a strong research and development network, opening avenues for joint ventures or licensing deals on emerging antifungal treatments.

Pipeline Development With advanced candidates like SCY-247 and a focus on second-generation fungers, there is potential to expand sales channels by targeting hospitals, clinics, and infectious disease specialists seeking new solutions for drug-resistant fungi.

Funding & Growth Having secured $45 million in funding alongside annual revenues up to $250 million, SCYNEXIS demonstrates financial stability that can support strategic expansion and investments in commercialization efforts.

Market Engagement Active participation in industry conferences and research events indicates SCYNEXIS’s commitment to raising product visibility, creating opportunities to approach decision-makers involved in infectious disease management and antimicrobial innovation.

SCYNEXIS, Inc. Tech Stack

SCYNEXIS, Inc. uses 8 technology products and services including UserWay, Google Fonts API, Google Charts, and more. Explore SCYNEXIS, Inc.'s tech stack below.

  • UserWay
    Accessibility
  • Google Fonts API
    Font Scripts
  • Google Charts
    Javascript Graphics
  • jQuery
    Javascript Libraries
  • Priority Hints
    Performance
  • Yoast SEO
    Search Engines
  • Google Analytics
    Web Analytics
  • QuoteMedia
    Widgets

Media & News

SCYNEXIS, Inc.'s Email Address Formats

SCYNEXIS, Inc. uses at least 1 format(s):
SCYNEXIS, Inc. Email FormatsExamplePercentage
First.Last@scynexis.comJohn.Doe@scynexis.com
97%
First_Last@scynexis.comJohn_Doe@scynexis.com
1%
LastFirst@scynexis.comDoeJohn@scynexis.com
1%
First.Middle@scynexis.comJohn.Michael@scynexis.com
1%

Frequently Asked Questions

Where is SCYNEXIS, Inc.'s headquarters located?

Minus sign iconPlus sign iconSCYNEXIS, Inc.'s main headquarters is located at Jersey City, New Jersey 07302 United States. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is SCYNEXIS, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact SCYNEXIS, Inc.'s main corporate office by phone at
+1-201-884-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SCYNEXIS, Inc.'s stock symbol?

Minus sign iconPlus sign iconSCYNEXIS, Inc. is a publicly traded company; the company's stock symbol is SCYX.

What is SCYNEXIS, Inc.'s official website and social media links?

Minus sign iconPlus sign iconSCYNEXIS, Inc.'s official website is scynexis.com and has social profiles on LinkedInCrunchbase.

What is SCYNEXIS, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconSCYNEXIS, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SCYNEXIS, Inc. have currently?

Minus sign iconPlus sign iconAs of March 2026, SCYNEXIS, Inc. has approximately 49 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer: D. A.Chief Financial Officer: I. M.Chief Legal Officer: S. S.. Explore SCYNEXIS, Inc.'s employee directory with LeadIQ.

What industry does SCYNEXIS, Inc. belong to?

Minus sign iconPlus sign iconSCYNEXIS, Inc. operates in the Biotechnology Research industry.

What technology does SCYNEXIS, Inc. use?

Minus sign iconPlus sign iconSCYNEXIS, Inc.'s tech stack includes UserWayGoogle Fonts APIGoogle ChartsjQueryPriority HintsYoast SEOGoogle AnalyticsQuoteMedia.

What is SCYNEXIS, Inc.'s email format?

Minus sign iconPlus sign iconSCYNEXIS, Inc.'s email format typically follows the pattern of First.Last@scynexis.com. Find more SCYNEXIS, Inc. email formats with LeadIQ.

How much funding has SCYNEXIS, Inc. raised to date?

Minus sign iconPlus sign icon As of March 2026, SCYNEXIS, Inc. has raised $45M in funding. The last funding round occurred on Apr 22, 2022 for $45M.

When was SCYNEXIS, Inc. founded?

Minus sign iconPlus sign iconSCYNEXIS, Inc. was founded in 2000.

SCYNEXIS, Inc.

Biotechnology ResearchNew Jersey, United States11-50 Employees

At SCYNEXIS, we are bringing a ground-breaking class of drugs to the battle by developing innovative products that have the strength, safety, and versatility to defeat even the most insidious fungal diseases.

We are committed to positively impacting the lives of patients suffering from fungal infections — from the most common to the difficult-to-treat and deadliest.

(NASDAQ: SCYX)

The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization.

Section iconCompany Overview

Headquarters
Jersey City, New Jersey 07302 United States
Phone number
+1-201-884-****
Website
scynexis.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SCYX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $45M

    SCYNEXIS, Inc. has raised a total of $45M of funding over 7 rounds. Their latest funding round was raised on Apr 22, 2022 in the amount of $45M.

  • $100M$250M

    SCYNEXIS, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $45M

    SCYNEXIS, Inc. has raised a total of $45M of funding over 7 rounds. Their latest funding round was raised on Apr 22, 2022 in the amount of $45M.

  • $100M$250M

    SCYNEXIS, Inc.'s revenue is estimated to be in the range of $100M$250M

Company Leadership

  • Stylized image of a person
    D. A.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. M.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S.
    Chief Legal Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. A.
    Vice President Of Clinical Development And Medical Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. G.
    Head Of Human Resources & Information Technology
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. A.
    Head Of Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. T.
    Head Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. A.
    Vice President Of Clinical Development And Medical Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. T.
    Executive Director, Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. M.
    Director, Cmc
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.